Controlling nuclear receptors: The circular logic of cofactor cycles

Nature Reviews Molecular Cell Biology

Volumn 6, Issue 7, 2005, Pages 542-554

  Perissi, Valentina ^a   Rosenfeld, Michael G ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ACTIN; ACTIN BINDING PROTEIN; CATHEPSIN D; CELL NUCLEUS RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 7; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALLIKREIN; LIVER X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEASOME; PROTEIN KINASE C; RECEPTOR INTERACTING PROTEIN 140; REGULATOR PROTEIN; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; RNA POLYMERASE; STEROID RECEPTOR; STEROIDOGENIC FACTOR 1; STRESS ACTIVATED PROTEIN KINASE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TREFOIL PEPTIDE;

ACETYLATION; CELL CYCLE; CYTOKINE PRODUCTION; DNA BINDING; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENOME; HUMAN; IMMUNOPRECIPITATION; KINETICS; METHYLATION; MODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MAMMALS; MODELS, MOLECULAR; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

LOTUS;

EID: 21744435965     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1680     Document Type: Review

References (159)

1. Aranda, A. & Pascual, A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269-1304 (2001).
2. Gronemeyer, H., Gustafsson, J. A. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nature Rev. Drug Discov. 3, 950-964 (2004).
3. Giguere, V. Orphan nuclear receptors: from gene to function. Endocr. Rev. 20, 689-725 (1999).
4. Sluder, A. E., Mathews, S. W., Hough, D., Yin, V. P. & Maina, C. V. The nuclear receptor superfamily has undergone extensive proliferation and diversification in nematodes. Genome Res. 9, 103-120 (1999).
5. Maglich, J. M. et al. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2, RESEARCH0029(2001).
6. Weston, A. D., Blumberg, B. & Underbill, T. M. Active repression by unliganded retinoid receptors in development: less is sometimes more. J. Cell Biol. 161 223-228 (2003).
7. Nettles, K. W. & Greene, G. L. Ligand control of coregulator recruitment of nuclear receptors. Annu. Rev. Physiol. 67, 309-333 (2004). References 7 and 9 provide comprehensive reviews of the molecular switch from transcriptional repression to activation, which focuses on the conformational changes in the receptor and summarizes crystallographic studies of the interactions of cofactors with nuclear receptors.
8. McKenna, N. J., Lanz, R. B. & O'Malley, B. W. Nuclear receptor coregulators cellular and molecular biology, Endocr. Rev. 20, 321-344 (1999).
9. Nagy, L. & Schwabe, J. W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29, 317-324 (2004).
10. White, J. H., Fernandes, I., Mader, S. & Yang, X. J. Corepressor recruitment by agonist-bound nuclear receptors. Vitam. Horm. 68, 123-143 (2004).
11. Delage-Mourroux, R. et al. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275, 35848-35856 (2000).
12. Chiba, H., Muramatsu, M., Nomoto, A. & Kato, H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res. 22, 1815-1820 (1994).
13. Underhill, C., Qutob, M. S., Yee, S. P. & Torchia, J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275, 40463-40470 (2000).
14. Fryer, C, J. & Archer, T. K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393, 88-91 (1998).
15. Sif, S., Saurin, A. J., Imbalzano, A. N. & Kingston, R. E. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15, 603-618 (2001).
16. Metivier, R, et al. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763 (2003). Detailed description of the ordered and cyclical recruitment of several cofactor complexes to the oestrogen-regulated pS2 promoter in MCF7 breast cancer cells.
17. Dilworth, F. J. & Chambon, P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20, 3047-3054 (2001).
18. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
19. Travers, A. An engine for nucleosome remodeling. Cell 96, 311-314 (1999).
20. Lanz, R. B. et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97, 17-27 (1999).
21. Kumar, R., Wang, R. A. & Barnes, C, J. Coregulators and chromatin remodeling in transcriptional control. Mol. Carcinog 41, 221-230 (2004).
22. +-regulated dehydrogenase. Mol. Cell 10, 857-869 (2002).
23. Vo, N., Fjeld, C. & Goodman, R. H. Acetylation of nuclear hormone receptor-interacting protein RIP 140 regulates binding of the transcriptional corepressor CtBP Mol. Cell. Biol. 21, 6181-6188 (2001). First example of acetylation of a corepressor as a way to regulate Its transcriptional activity by modulating protein-protein interactions.
24. Lee, Y. H., Campbell, H. D. & Stallcup, M. R. Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity. Mol. Cell. Biol. 24, 2103-2117 (2004).
25. Huang, S. M., Huang, C. J., Wang, W. M., Kang, J. C. & Hsu, W. C. The enhancement of nuclear receptor transcriptional activation by a mouse actin-binding protein, α actinin 2. J. Mol. Endocrinol. 32, 481-496 (2004).
26. Loy, C. J., Sim, K. S. & Yong, E. L. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc. Natl Acad. Sci. USA 100, 4562-4567 (2003).
27. Yoon, H, G. et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1, EMBO J. 22, 1336-1346 (2003).
28. Nishimura, K. et al. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res. 63, 4888-4894 (2003).
29. Ting, H. J., Yeh, S., Nishimura, K. & Chang, C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc. Natl Acad. Sci. USA 99, 661-666 (2002).
30. Hermanson, O., Glass, C. K. & Rosenfeld, M. G. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13, 55-60 (2002).
31. Privalsky, M. L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66, 315-360 (2004).
32. Cosma, M. P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol. Cell 10, 227-236 (2002).
33. Kraus, W. L. & Wong, J. Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? Eur. J. Biochem. 269, 2275-2283 (2002).
34. Bultman, S. et al. A Brg1 null mutation In the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6, 1287-1295 (2000).
35. Kadam, S. & Emerson, B. M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 11, 377-389 (2003).
36. Reyes, J. C. et al. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α). EMBO J. 17, 6979-6991 (1998).
37. Wang, W. et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15, 5370-5382 (1996).
38. DiRenzo, J. et al. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol. Cell. Biol. 20, 7541-7549 (2000).
39. Lemon, B., Inouye, C., King, D. S. & Tjian, R. Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. Nature 414, 924-928 (2001).
40. Glass, C. K. & Rosenfeld, M. G. The coregulator exchange in transcriptional functions of nuclear receptors Genes Dev. 14, 121-41 (2000).
41. McKenna, N. J. & O'Malley, B. W. Minireview: nuclear receptor coactivators -an update. Endocrinology 143, 2461-2465 (2002).
42. Iborra, F. J., Pombo, A., Jackson, D. A. & Cook, P. R. Active RNA polymerases are localized within discrete transcription 'factories' In human nuclei. J. Cell Sci. 109, 1427-1436 (1996).
43. Jackson, D. A., Hassan, A. B., Errington, R. J. & Cook, P. R. Visualization of focal sites of transcription within human nuclei. EMBO J. 12, 1059-1065 (1993).
44. Osborne, C. S. et al. Active genes dynamically coiocalize to shared sites of ongoing transcription. Nature Genet. 36, 1065-1071 (2004). Dynamic colocalization of distal active genes into discrete nuclear subcompartments or 'transcription factories'.
45. Bettinger, B. T., Gilbert, D. M. & Amberg, D. C. Actin up in the nucleus. Nature Rev. Mol. Cell Biol. 5, 410-415 (2004).
46. Olave, I. A., Reck-Peterson, S. L. & Crabtree, G. R. Nuclear actin and actln-related proteins in chromatin remodeling. Annu. Rev. Biochem. 71, 755-781 (2002).
47. Szentirmay, M. N. & Sawadogo, M. Spatial organization of RNA polymerase II transcription in the nudeus. Nucleic Acids Res. 28, 2019-2025 (2000).
48. Cook, P. R. Nongenic transcription, gene regulation and action at a distance. J. Cell Sci. 116, 4483-4491 (2003).
49. Stein, G. S. et al. Functional architecture of the nucleus: organizing the regulatory machinery for gene expression, replication and repair. Trends Cell Biol. 13, 584-592 (2003).
50. Shang, Y. & Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468 (2002). Promoter-specific and tissue-specific recruitment of coregulatory proteins by an antagonist-bound oestrogen receptor in uterine and breast cancer cells.
51. Cosma, M. P., Tanaka, T. & Nasmyth, K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmental regulated promoter. Cell 97, 299-311 (1999). First example of the ordered recruitment of cofactor complexes to a regulated transcription unit.
52. Dilworth, F. J., Fromental-Ramain, C., Yamamoto, K. & Chambon, P. ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol. Cell 6, 1049-1058 (2000).
53. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. & Brown, M, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852 (2000). Analysis of the occupancy of the CATD promoter following ligand activation: first description of an ordered and cyclical recruitment of different cofactors by nuclear receptors in a mammalian system.
54. Kang, Z., Pirskanen, A., Janne, O. A. & Palvimo, J. J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277, 48366-48371 (2002).
55. Reid, G. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded Erα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707 (2003).
56. Sharma, D, & Fondell, J. D. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl Acad Sci. USA 99, 7934-7939 (2002).
57. Grenier, J. et al. Selective recruitment of p160 coactivators on glucocorticoid-negulated promoters in Schwann cells. Mol. Endocrinol. 18, 2866-2879 (2004).
58. Suen, C. S. et al. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J. Biol. Chem. 273, 27645-27653 (1998).
59. Li, X., Wong, J., Tsai, S. Y., Tsai, M. J. & O'Malley, B. W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 23, 3763-3773 (2003).
60. Liu, X. F. & Bagchi, M. K. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J. Biol. Chem. 279, 15050-15058 (2004).
61. Metivier, R. et al. Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes. EMBO J. 23, 3653-3666 (2004).
62. Vermeulen, M. et al. In vitro targeting reveals intrinsic histone tail specificity of the Sin3/histone deacetylase and N-CoR/SMRT corepressor complexes. Mol. Cell. Biol. 24, 2364-2372 (2004).
63. Kurokawa, R. et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451-454 (1995).
64. Klinge, C. M., Jernigan, S. C., Mattingly, K. A., Risinger, K. E. & Zhang, J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors. J. Mol. Endocrinol. 33, 387-410 (2004).
65. Loven, M. A., Likhite, V. S., Choi, I. & Nardulli, A. M. Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor β conformation. J. Biol. Chem. 276, 45282-45288 (2001).
66. Rogatsky, I. et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 100, 13845-138450 (2003).
67. Narlikar, G. J., Fan, H. Y. & Kingston, R. E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487 (2002).
68. McNally, J. G., Muiler, W. G., Walker, D., Wolford, R. & Hager, G. L. The giucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287, 1262-1265 (2000). First paper to show nuclear receptor binding to a DNA response element in real time, in living cells, using fluorescence recovery after photobleaching (FRAP) and fluorescence loss in photobleaching (FLIP) techniques.
69. Nagaich, A. K., Walker, D. A., Wolford, R. & Hager, G. L. Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol. Cell 14, 163-174 (2004). Novel UV-laser crosslinking technique used to analyse the ultra-rapid binding of GR and associated complexes on a multimerized array of the MMTV promoter.
70. Hoberg, J. E., Yeung, F. & Mayo, M. W. SMRT derepression by the IκB kinase α a prerequisite to NF-κB transcription and survival. Mol. Cell 16, 245-255 (2004). Exchange of a corepressor for a coactivator on NF-κB requires SMRT phopshorylation by IKKα
71. Perissi, V., Aggarwal, A., Glass, C. K., Rose, D. W. & Rosenfeld, M. G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors Cell 116, 511-526 (2004). Identification of an ubiquitylation/degradation event required to release the NCoR corepressor complex from activated nuclear receptors.
72. Freeman, B. C. & Yamamoto, K. R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296, 2232-2235 (2002). Involvement of chaperone proteins in transcriptional regulation by mediating promoter clearance.
73. Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B. & Tansey, W. P. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl Acad. Sci. USA 97, 3118-3123 (2000).
74. Molinari, E., Gilman, M. & Natesan, S. Proteasome-mediated degradation of transcriptionai activators correlates with activation domain potency in vivo. EMBO J. 18, 6439-6447 (1999).
75. Lonard, D. M., Nawaz, Z. Smith, C. L. & O'Malley, B. W. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-á transactivation. Mol. Cell 5, 939-948 (2000).
76. Lin, H. K. et al. Proteasome activity is required for androgen receptor transcriptionai activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277, 36570-36576 (2002).
77. Gianni, M., Bauer, A., Garattini, E., Chambon, P. & Rochette-Egly, C, Phosphorylation by pSSMAPK and recruitment of SUG-1 are required for RA-induced RAR γ degradation and transactivation. EMBO J. 21, 3760-3769 (2002).
78. Alarid, E. T., Bakopoulos, N. & Solodin, N. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation Mol. Endocrinol. 13, 1522-1534 (1999).
79. Dace, A. et al. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc. Natl Acad. Sci. USA 97, 8985-8990 (2000).
80. Floyd, Z. E. & Stephens, J. M. Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes. J. Biol. Chem. 277, 4062-4068 (2002).
81. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L. & O'Malley, B. W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl Acad. Sci. USA 96, 1858-1862 (1999).
82. Zhu, J. et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor aipha (RARα) and oncogenic RARα fusion proteins. Proc. Natl Acad. Sci USA 96, 14807-14812 (1999).
83. Van, R., Gao, X., Lonard, D. M. & Nawaz, Z. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators. Mol. Endocrinol. 17, 1315-1331 (2003).
84. Wallace, A. D. & Cidlowski, J. A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptionai signaling by glucocorticoids. J Biol. Chem. 276, 42714-42721 (2001).
85. Boudjelal, M., Voorhees, J. J. & Fisher, G. J. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells. Exp. Cell Res. 274, 130-137 (2002).
86. Fan, M., Nakshatri, H. & Nephew, K. P. Inhibiting proteasomal proteolysis sustains estrogen receptor-α activation. Mol. Endocrinol. 18, 2603-2615 (2004).
87. Jacob, F. & Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318-356 (1961).
88. Li, J. et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350 (2000).
89. Tomita, A., Buchholz, D. R. & Shi, Y. B. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development. Mol. Cell. Biol. 24, 3337-3346 (2004).
90. Ogawa, S, et al. A nuclear receptor corepressor transcriptionai checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl Acad. Sci. USA 101, 14461-14466 (2004).
91. McKenna, N. J. & O'Malley, B. W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474 (2002).
92. Sengupta, N. & Seto, E. Regulation of histone deacetylase activities. J. Cell. Biochem. 93, 57-67 (2004).
93. Baek, S. H. & Rosenfeld, M. G. Nuclear receptor coregulators: their modification codes and regulatory mechanism by transiocation. Biochem. Biophys. Res. Commun. 319, 707-714 (2004).
94. Fischte, W., Wang, Y. & Allis, C. D. Histone and chromatin cross-talk, Curr. Opin. Cell Biol. 15, 172-183 (2003).
95. Rochette-Egly, C. et al. Phosphorylation of the retinoic acid receptor-α by protein kinase A. Mol. Endocrinol. 9, 860-871 (1995).
96. Delmotte, M. H., Tahayato, A., Formstecher, P. & Lefebvre, P. Serine 157, a retinoic acid receptor α residue phosphorylated by protein kinase C in vitro, is involved in RXR-RARα heterodimerization and transcriptionai activity. J. Biol. Chem. 274, 38225-38231 (1999).
97. Adam-Stitah, S., Penna, L., Chambon, P. & Rochette-Egly, C. Hyperphosphorylation of the retinoid X receptor α by activated c-Jun NH2-terminal kinases. J. Biol. Chem. 274, 18932-18941 (1999).
98. Bastien, J. et al. TFIIH interacts with the retinoic acid receptor γ and phosphoryiates its AF-1-activating domain through cdk7. J. Biol. Chem. 275, 21896-21904 (2000).
99. Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J. M. & Chambon, P. Stimulation of RAR α activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90, 97-107 (1997).
100. Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C. & Egly, J. M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109, 125-135 (2002). Genetic significance of the regulation of RAR by phosphorylation.
101. Kopf, E. et al. Dimerization with retinoid X receptors and phosphoryiation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway. J. Biol. Chem. 275, 33280-33288 (2000).
102. Goodman, R. H. & Smolik, S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577 (2000).
103. Chan, H. M. & La Thangue, N. B. p300/GBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363-2373 (2001).
104. Yaciuk, P. & Moran, E. Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol. Cell. Biol. 11, 5389-5397 (1991).
105. Banerjee, A. C. et al. The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300. Oncogene 9, 1733-1737 (1994).
106. Perkins, N. D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527 (1997).
107. Ait-Si-Ali, S, et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396, 184-186 (1998).
108. Kitabayashi, I. et al. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells EMBO J. 14, 3496-3509 (1995).
109. Chakravarti, D. et al. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403 (1999).
110. Hamamori, Y. et al. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413 (1999).
111. Perissi, V. et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc. Natl Acad. Sci USA 96, 3652-3657 (1999).
112. Xu, L. et al. Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395, 301-306 (1998).
113. Chawla, S., Hardingham, G. E., Quinn, D. R. & Bading, H. CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science 281, 1505-1509 (1998).
114. Janknecht, R. & Nordheim, A. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBR Biochem. Biophys. Res. Commun. 228, 831-837 (1996).
115. Ait-Si-Ali, S. et al. Phosphorylation by p44 MAP Kinase/ ERK1 stimulates CBP histone acetyl transferase activity in vitro Biochem. Biophys. Res. Commun. 262, 157-162 (1999).
116. Yuan, L. W. & Gambee, J. E. Phosphorylation of p300 at serine 89 by protein kinase C. J. Biol. Chem. 275, 40946-40951 (2000)
117. Impey, S. et al. Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34, 235-244 (2002). Example of the physiological relevance of the regulation of CBP function by phosphorylation.
118. Xu, W. et al. A transcriptional switch mediated by cofactor methylation. Science 294, 2507-2511 (2001).
119. Brouillard, F. & Cremisi, C. E. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells. J. Biol. Chem. 278, 39509-39516 (2003).
120. Iwao, K., Kawasaki, H., Taira, K. & Yokoyama, K. K. Ubiquitination of the transcriptional coactivator p300 during retinoic acid induced differentiation. Nucleic Acids Symp. Ser. 42, 207-208 (1999).
121. Jones, P. L. & Shi, Y. B. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr. Top. Microbiol. Immunol. 274, 237-268 (2003).
122. Zhang, J., Kalkum, M., Chait, B. T. & Roeder, R. G. The N-CoR-HDACS nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611-623 (2002).
123. Guenther, M. G., Barak, O. & Lazar, M. A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetyiase 3. Mol. Cell. Biol. 21, 6091-6101 (2001).
124. Baek, S. H. et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110, 55-67 (2002).
125. Hong, S. H. & Privalsky, M. L. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell. Biol. 20, 6612-6625 (2000).
126. Zhou, Y., Gross, W., Hong, S. H. & Privalsky, M. L. The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol. Cell. Biochem. 220, 1-13 (2001).
127. Jonas, B. A. & Privaisky, M. L. SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J. Biol. Chem. 279, 54676-54686 (2004).
128. Cardozo, T. & Pagano, M. The SCF ubiquitin ligase: insights into a molecular machine. Nature Rev. Mol. Cell Biol. 5, 739-751 (2004).
129. Anest, V. et al. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659-663 (2003).
130. Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T. & Gaynor, R. B. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655-659 (2003).
131. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382 (1995).
132. Renaud, J. P. et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689 (1995).
133. Darimont, B. D. et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (1998).
134. Wagner, R. L. et al. A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
135. Brzozowski, A. M. et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758 (1997).
136. Shiau, A. K. et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction bytamoxifen. Cell 95, 927-937 (1998).
137. Nolte, R. T. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143 (1998).
138. Heery, D. M., Kalkhoven, E., Hoare, S. & Parker, M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736 (1997).
139. Torchia, J. et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684 (1997).
140. Nagy, L. et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13, 3209-3216 (1999).
141. Perissi, V. et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13, 3198-3208 (1999).
142. Hu, X. & Lazar, M. A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96 (1999).
143. Huang, H. J., Norris, J, D. & McDonnell, D. P. Identification of a negative regulatory surface within estrogen receptor α provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol. Endocrinol. 16, 1778-1792 (2002).
144. Losel, R. & Wehling, M. Nongenomic actions of steroid hormones. Nature Rev. Mol. Cell Biol. 4, 46-56 (2003).
145. Koh, S. S., Chen, D., Lee, Y. H. & Stallcup, M. R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 276, 1089-1098 (2001).
146. Wang, H. et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293, 853-857 (2001).
147. Xu, W. et al. A methylation-mediator complex in hormone signaling. Genes Dev. 18, 144-156 (2004). Biochemical purification of the CARM1 complex, which indicates a direct association between ATP-dependent chromatin remodelling complexes and arginine methyltransferases.
148. Brady, M. E. et al. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274, 17599-17604 (1999).
149. Yanagisawa, J. et al. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol. Cell 9, 553-562 (2002).
150. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
151. Fondell, J. D., Ge, H. & Roeder, R. G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl Acad. Sci. USA 93, 8329-8333 (1996).
152. Ito, M. et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell 3, 361-370 (1999).
153. Naar, A. M. et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398, 828-832 (1999).
154. Rachez, C. et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828 (1999).
155. Wade, P. A., Jones, P. L., Vermaak, D. & Wolffe, A. P. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr. Biol. 8, 843-846 (1998).
156. Zhang, Y., LeRoy, G., Seelig, H. P., Lane, W. S. & Reinberg, D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95, 279-289 (1998).
157. Xue, Y. et al. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell 2, 851-861 (1998).
158. Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E. & Schreiber, S. L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395, 917-921 (1998).
159. Shi, Y. et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738 (2003).